If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.60
Low: 0.60
Prev. Close: 0.60
KZG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

29 Mar 2023 07:00

RNS Number : 5396U
Kazera Global PLC
29 March 2023
 

29 March 2023

Kazera Global plc ('Kazera' or 'the Company')

 

Interim Results

 

Kazera Global plc, the AIM-quoted investment company, announces its unaudited Interim Results for the six months ended 31 December 2022.

 

Highlights

· Receipt of mining permit for Walviskop Heavy Mineral Sands (HMS) Project

· Commenced initial production of HMS in December 2022

· Diamond mine pan plant installed and commissioned at Alexander Bay Diamond Project

· Ongoing disposal of African Tantalum (Pty) Ltd ('Aftan') for cash consideration of US$13m

· Cash at 27 March 2023 of £1,258k

 

 

Dennis Edmonds, CEO of Kazera Global, said: "We remain committed to strengthening our position as a well-funded, commodity diverse, mining investment company, and developing early-stage assets towards meaningful cash flow and resource realisation. 

 

"Accordingly, towards the end of the period under review, we were delighted to announce the disposal of Aftan to Hebei Xinjian Construction ('Xinjian') for US$13m cash payable in several tranches to December 2023. Notably, Kazera is retaining the right to receive a debenture payment equivalent to 2.5% of gross sales of produced lithium and tantalum for the life of the Tantalite Valley Mine, and 100% ownership remains with us until Kazera is paid in full. In the interim, all costs are carried by Xinjian.

 

"This first realisation of returns from an investment is in line with our strategy and allows us to invest in our other assets without the need for additional capital raising, namely Whale Head Minerals (Pty) Ltd, which operates the Walviskop Heavy Mineral Sands Project ('Walviskop'), and Deep Blue Minerals (Pty) Ltd, which operates the Alexander Bay Diamond Project.

 

"Walviskop is a five-hectare beach sand deposit with a minimum 1.5Mt at 49.9% purity, predominantly ilmenite and garnet, which will be replenished by wave action; zircon and rutile are also present but have not been included in the modelling. Having placed an order for a screening plant to separate out the silica from the HMS and to create a saleable HMS concentrate, we expect the project to generate positive cashflow within the next six months and produce circa 6Kt HMS per month, achieving an estimated gross profit in excess of US$300,000 per month at current prices.

 

"Progress is also being made at the Alexander Bay Diamond Project, which is located within the 80km long Alexkor diamond fields and lying between two historic De Beers operations. With an estimated circa 2 million carats left in the tenement, mining is undertaken on a sub-contract basis from Alexkor, a government owned entity, which has the rights to all the diamonds in the area. During the period, Kazera undertook the development of a new processing facility, which is now complete and capable of handling 70 tons per hour of raw material.

 

"Post period end, we were delighted to welcome a new strategic investor to our register, AMS, which has extensive experience in mining and infrastructure projects. Having agreed to acquire a 29.9% interest in the Company at a 53% premium to the price per Ordinary Share immediately prior to the suspension of Kazera's trading on AIM, AMS clearly recognises the value of your company.

 

"Looking ahead, with cash in hand, a supportive strategic investor in AMS, and clear path towards increasing scalable production at Walviskop providing us with a highly cash generative platform with which to grow the Company further, I remain highly optimistic for 2023 and beyond. 

 

"Finally, I would like to take this opportunity to thank the Board and management team for their continued hard work and support and look forward to providing regular updates on our progress as we focus on realising the potential of our investments and generating value for our shareholders."

 

 

Further payment from Xinjian

Since its announcement on 16 March 2023, the Company has received a further proof of payment of US$500k from Xinjian towards its purchase of Kazera's interest in Aftan, which is expected to be received imminently; the sale remains on track to complete in December 2023. This amount is not included in the calculation of the group's cash balance as stated above, of £1,258k.

 

 

Update re new strategic shareholder

Further to the Company's announcement on 16 March 2023, in which it was stated that, "The Company has been advised that the purchase will take place in a series of tranches during 2023, with all voting rights passing to the purchaser on payment of the first tranche.", the Company has since been advised that voting rights will pass to the purchaser on payment of the second tranche, not the first tranche as previously stated. Any further updates relating to the changes in shareholdings will be announced in accordance with the AIM Rules upon receipt of any notification in accordance with the Disclosure and Transparency Rules.

 

 

For further information on the Company, visit: www.kazeraglobal.com.

 

Kazera Global plc

Dennis Edmonds, CEO

 

kazera@stbridespartners.co.uk

 

finnCap (Nominated Adviser and Joint broker)

Christopher Raggett / Fergus Sullivan (Corporate Finance)

 

Tel: +44 (0)207 220 0500

St Brides Partners (Financial PR)

Paul Dulieu / Isabel de Salis / Will Turner

 

kazera@stbridespartners.co.uk

 

 

Condensed Consolidated Statement of Comprehensive Income

for the six-months ended 31 December 2022

 

 

 

Notes

Six months ended

31 December

2022

Unaudited

Six months ended

31 December

2021

Unaudited

Continuing operations

 

£'000

£'000

 

Revenue

50

100

Cost of sales

-

(100)

Gross profit

50

-

Pre-production expenses

-

(72)

Administrative expenses

(531)

(529)

Operating loss before taxation

(481)

(601)

 

Income tax

-

-

Loss for the period

(481)

(601)

 

 

Total comprehensive income

 

Loss attributable to owners of the Company

(496)

(589)

Non-controlling interests

15

(12)

 

(481)

(601)

 

Other comprehensive income

 

Exchange gains/(losses) on translation of foreign operations

261

(210)

Other comprehensive income for the period, net of tax

261

(210)

 

 

Total comprehensive income attributable to the owners of the Company

(235)

(799)

 

 

Earnings per share:

 

Basic and diluted loss per share (pence)

3

(0.05)p

(0.08)p

 

 

 

 

 

Condensed Consolidated Statement of Financial Position

As at 31 December 2022

 

 

 

Notes

31 December 2022

Unaudited

30 June 2022

Audited

 

 

£'000

£'000

Non-current assets

 

Mines under construction

2,912

2,961

Property, plant and equipment

741

796

Total non-current assets

3,653

3,757

 

Current assets

 

Trade and other receivables

466

279

Cash and cash equivalents

595

637

Current assets

1,061

916

Total assets

4,714

4,673

 

Current liabilities

 

Trade and other payables

4

1,718

652

Total current liabilities

1,718

652

Non-current liabilities

Other payables

-

826

Provisions

55

54

Total non-current liabilities

55

880

Total liabilities

1,771

1,532

Net assets

2,942

3,141

Equity attributable to owners of the parent

Share Capital

3,516

3,516

Share Premium

17,556

17,556

Capital redemption reserve

2,077

2,077

Share-based payments reserve

463

443

Foreign exchange reserve

(233)

(494)

Retained Earnings

(20,403)

(19,908)

Equity attributable to owners of the Company

 

2,976

3,190

Non-controlling interests

 

(34)

(49)

Total equity

 

2,942

3,141

Condensed Consolidated Statement of Changes in Equity

for the six-month period ended 31 December 2022

 

 

Unaudited

 

Share Capital

£'000

 

Share Premium

£'000

Capital redemption reserve £'000

Share-based payment reserve £'000

Foreign exchange reserve £'000

 

Retained earnings £'000

Equity attributable to owners £'000

Non-controlling interests £'000

 

 

Total equity £'000

 

1 July 2021

3,279

15,863

2,077

337

(477)

(17,917)

3,162

(29)

3,133

Loss for the period

-

-

-

-

-

(589)

(589)

(12)

(601)

Other comprehensive income:

Exchange movement on translation of foreign operations

-

-

-

-

(210)

-

(210)

-

(210)

Total comprehensive income for the period

-

-

-

-

(210)

(589)

(799)

(12)

(811)

Transactions with owners:

Issue of share capital

61

454

-

-

-

-

515

-

515

Share-based payment charges

-

-

-

55

-

-

55

-

55

Total transactions with owners, recognised directly in equity

61

454

-

55

-

-

570

-

570

Balance at 31 December 2021

3,340

16,317

2,077

392

(687)

(18,506)

2,933

(41)

2,892

 

 

Unaudited

 

Share Capital

£'000

 

Share Premium

£'000

Capital redemption reserve £'000

Share-based payment reserve £'000

Foreign exchange reserve £'000

 

Retained earnings £'000

Equity attributable to owners £'000

Non-controlling interests £'000

 

 

Total equity £'000

 

1 July 2022

3,516

17,556

2,077

443

(494)

(19,908)

3,190

(49)

3,141

Loss for the period

-

-

-

-

-

(496)

(496)

15

(481)

Other comprehensive income:

Exchange movement on translation of foreign operations

-

-

-

-

261

-

261

-

261

Total comprehensive income for the period

-

-

-

-

261

(496)

(235)

15

(220)

Transactions with owners:

Share-based payment charges

-

-

-

20

-

-

20

-

20

Total transactions with owners, recognised directly in equity

-

-

-

20

-

-

20

-

20

Balance at 31 December 2022

3,516

 

17,556

 

2,077

 

463

 

(233)

 

 

(20,403)

 

2,976

 

(34)

 

2,942

 

Condensed Consolidated Statement of Cash Flows

for the six-month period ended 31 December 2022

 

 

Six months to

31 December

2022

Unaudited

Six months to

31 December

2021

Unaudited

 

 

£'000

£'000

 Cash flows from operating activities

Loss before taxation

(481)

(601)

Depreciation

63

65

Net foreign exchange

(378)

(143)

Share-based payments charge and other non-cash items

20

55

Net cashflow before changes in working capital

(776)

(624)

Increase in receivables

(186)

(24)

Increase in payables

243

427

Net cash used in operating activities

(719)

(220)

 

 

Cash flows from investing activities

 

Development costs

(26)

(259)

Proceeds from proposed sale of investment

828

-

Net cash generated from/(used) in investing activities

802

(259)

 

 

 

 

Cash flows from financing activities

 

 

 

Issue of share capital

-

515

Repayment of borrowings

(125)

-

Net cash (used in)/generated from financing activities

(125)

515

 

 

Net (decrease)/increase in cash and cash equivalents during the period

(42)

36

Cash at the beginning of period

 

637

47

 

Cash and cash equivalents at the end of the period

 

595

83

 

 

Notes to the condensed consolidated interim financial information

 

1 GENERAL INFORMATION

Kazera is public limited company incorporated and domiciled in the United Kingdom; its Ordinary shares are quoted on AIM of the London Stock Exchange.

 

 

2 BASIS OF PREPARATION

The accounting policies, methods of computation and presentation used in the preparation of the condensed consolidated interim financial information are the same as those used in the Group's audited financial statements for the year ended 30 June 2022. There have been no changes to the reported figures as a result of any new reporting standards or interpretations.

 

Basis of preparation

The condensed interim financial statements have been prepared in accordance with the requirements of the AIM Rules for Companies. As permitted, the Company has chosen not to adopt IAS 34 "Interim Financial Statements" in preparing this interim financial information. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 30 June 2022, which have been prepared in accordance with international accounting standards in conformity with the Companies Act 2006.

 

The financial information set out in this interim report is unaudited and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The Company's statutory financial statements for the period ended 30 June 2022, prepared under international accounting standards in conformity with the Companies Act 2006, have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under section 498 (2) or (3) of the Companies Act 2006.

 

Comparatives

The Group has presented comparatives for the statement of comprehensive income, statement of cash flows and statement of changes in equity for the six months ended 31 December 2021; and a statement of financial position as at 30 June 2022 in accordance with the requirements of the AIM Rules for Companies.

 

Risks and uncertainties

The Board continuously assesses and monitors the key risks of the business. The key risks that could affect the Company's medium-term performance and the factors that mitigate those risks have not substantially changed from those set out in the Company's 2022 Annual Report and Financial Statements, a copy of which is available on the Company's website, www.kazeraminerals.com.

 

Critical accounting estimates and judgements

The preparation of condensed interim financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the end of the reporting period. Significant items subject to such estimates are set out in the Company's 2022 Annual Report and Financial Statements. The nature and amounts of such estimates have not changed during the interim period.

 

Going Concern

The financial position of the Group and cash flows as at 31 December 2022 are set out above. The Group meets its day-to-day working capital and other funding requirements with its current cash, raised through equity placings, revenue from its cash generating assets, and the disposal of African Tantalum (Pty) Ltd. On the basis of current financial projections (at least 12 months) the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence, and meet its liabilities as they fall due, for the foreseeable future. Accordingly, the Directors consider it appropriate to adopt the going concern basis in preparing this financial information.

3 EARNINGS PER SHARE

Basic earnings per share is calculated by dividing the loss attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the period.

 

 

Six months to

31 December

 2022

 

Six months to

31 December 2021

£'000s

£'000s

Loss from continuing operations attributable to equity holders of the Company

(496)

(589)

Weighted average number of ordinary shares in issue

937,164,911

744,005,591

 

 

Basic and fully diluted loss per share from continuing operations

(0.05)p

(0.08)p

 

 

4 TRADE AND OTHER PAYABLES

On 20 December 2022, the Company announced that it had entered into an agreement to sell its interest in 100% of the shares in African Tantalum (Pty) Ltd to Hebei Xinjian Construction ("Xinjian") for a cash sum of USD13 million (the "Transaction"); included in trade and other payables are amounts totalling £828k with respect to initial proceeds of the Transaction.

 

 

5 SHARE OPTIONS AND WARRANTS

The total number of share options and share warrants in issue as at 30 June 2022 and 31 December 2022 were as follows:

Share warrants

Exercise Price (p)

Expiry Date

At 30 June 2022

Issued

Exercised

Lapsed

At 31 December 2022

2.00

27/12/2022

10,000,000

-

-

10,000,000

-

2.00

27/12/2022

2,500,000

-

-

2,500,000

-

2.00

04/01/2023

5,000,000

-

-

-

5,000,000

2.00

12/01/2023

325,000

-

-

-

325,000

2.00

31/01/2023

10,000,000

-

-

-

10,000,000

2.00

01/02/2023

6,000,000

-

-

-

6,000,000

1.00

31/05/2023

157,331,500

-

-

-

157,331,500

1.00(1)

30/10/2023

39,397,643

-

-

-

39,722,643

189,354,143

-

-

12,500,000

179,179,143

 

(1) As required under the terms of the warrant instruments dated 27 October 2021, the exercise price of the warrants was adjusted to match the price at which equity issue announced on 5 May 2022.

 

Share options

Exercise Price (p)

Expiry Date

At 30 June 2022

Issued

Exercised

Lapsed

At 31 December 2022

1.75

20/12/2022

3,300,000

-

-

3,300,000

-

2.00

12/01/2023

1,500,000

-

-

-

1,500,000

1.75

20/12/2023

3,300,000

-

-

-

3,300,000

1.75

20/12/2024

3,400,000

-

-

-

3,400,000

1.00

03/06/2025

26,500,000

-

-

-

26,500,000

1.00

08/07/2027

-

3,000,000

3,000,000

1.00

18/07/2027

-

4,000,000

4,000,000

1.00

03/11/2027

-

1,500,000

-

-

1,500,000

1.00

03/11/2027

-

15,000,000

15,000,000

 

36,500,000

23,500,000

-

3,300,000

56,700,000

 

 

6 EVENTS AFTER THE REPORTING PERIOD

On 14 March 2023, Odilon Kasongo Ilunga, resigned as a director of the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR NKFBKCBKDONB
Date   Source Headline
1st Sep 20158:22 amRNSAftan Purchases Remaining 40% Stake in Project
21st Aug 20154:01 pmRNSHolding(s) in Company
3rd Aug 20157:00 amRNSOperational Update
30th Jul 20154:35 pmRNSPrice Monitoring Extension
27th Jul 20157:00 amRNSAward of Performance Shares to Director
16th Jul 20157:00 amRNSGranting of Options and Issue of Equity
15th Jul 20158:00 amRNSDirectorate Change
8th Jul 20157:00 amRNSPlacing Announcement & Appointment of Joint Broker
3rd Jul 20152:26 pmRNSRelated Party Loan
1st Jul 20159:49 amRNSCompletion of long term offtake agreement
19th Jun 20157:00 amRNSBoard Appointment
11th Jun 201510:09 amRNSBoard Appointment
31st Mar 20157:00 amRNSHalf Yearly Report
25th Mar 20151:16 pmRNSExercise of Warrants
29th Jan 20157:00 amRNSCompletion of Acquisition of Tantalite Mine
17th Dec 20147:00 amRNSAcquisition Update
15th Dec 20144:32 pmRNSResult of AGM
20th Nov 20145:10 pmRNSPosting of Accounts and Notice of AGM
14th Nov 20147:00 amRNSFinal Results
4th Aug 20147:52 amRNSConditional Investment in Tantalite Project
24th Apr 201411:31 amRNSResult of AGM
26th Mar 20145:06 pmRNSGrant of Options to Directors
25th Mar 20141:30 pmRNSPlacing and issue of equity
25th Mar 20141:17 pmRNSBoard Appointments and Placing
25th Mar 20147:01 amRNSNotice of AGM
24th Mar 20149:00 amRNSHalf Yearly Report
24th Dec 20138:54 amRNSFinal Results
17th Sep 20134:35 pmRNSPrice Monitoring Extension
6th Jun 20132:19 pmRNSHolding(s) in Company
3rd Jun 201311:27 amRNSHolding(s) in Company
24th May 20137:00 amRNSInvesting company update
11th Apr 20131:36 pmRNSHolding(s) in Company
11th Apr 20131:34 pmRNSHolding(s) in Company
8th Apr 20133:03 pmRNSDirectorate Change
27th Mar 20131:25 pmRNSHalf Yearly Report
1st Mar 201310:01 amRNSHolding(s) in Company
1st Mar 201310:00 amRNSHolding(s) in Company
8th Feb 20132:49 pmRNSHolding(s) in Company
8th Feb 20132:44 pmRNSHolding(s) in Company
4th Jan 201312:57 pmRNSHolding(s) in Company
29th Nov 201210:25 amRNSDirector/PDMR Shareholding
8th Nov 20123:22 pmRNSResult of AGM and Capital Re-organisation
5th Oct 201212:36 pmRNSAnnual Financial Report
28th Sep 20122:25 pmRNSFinal Results
12th Sep 20129:30 amRNSChange of accounting reference date
23rd Aug 20129:29 amRNSHolding(s) in Company
16th Aug 20122:36 pmRNSHolding(s) in Company
8th Aug 20124:24 pmRNSHolding(s) in Company
11th Jun 20123:48 pmRNSChange of Name
1st Jun 201210:53 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.